<DOC>
	<DOCNO>NCT01382017</DOCNO>
	<brief_summary>This study design explore dose-depended effect lacosamide ( LCM ) motor cortex excitability TMS randomize , double-blind , placebo-controlled crossover trial young healthy human subject , compare pattern excitability change induce LCM carbamazepine ( CBZ ) . LCM selectively enhance slow inactivation voltage-gated sodium channel , , contrast CBZ , affect steady-state fast inactivation ( Errington et al. , 2006 ) . The enhancement slow inactivation sodium channel LCM novel manner modulate sodium channel lead normalization activation threshold reduce pathophysiological hyper-responsiveness , thereby effectively control neuronal hyperexcitability without affect physiological activity ( Beyreuther et al. , 2007 ) . Therefore , think LCM , compare CBZ , well tolerate clinical setting even effective control seizure activity . On basis result nonhuman study , hypothesize TMS profile LCM distinguishable CBZ . CBZ , like 'classical ' sodium channel blocker phenytoin , predominantly demonstrate elevated TMS motor threshold indicate reduce neuronal membrane excitability , without develop significant change synaptic intracortical inhibition facilitation ( Ziemann et al. , 1996 ; Chen et al. , 1997 ; Lee et al. , 2005 ) . Because novel mode action speculate TMS parameter LCM might affect . For example , exclusively affect neuronal membrane excitability , LCM could possibly also affect inhibitory mechanisms short- long-latency intracortical inhibition ( Valls-Sole et al. , 1992 ; Kujirai et al. , 1993 ) . This would line well-tolerated modern antiepileptic drug ( Ziemann et al. , 1996 ; Reis et al. , 2002 ; Lang et al. , 2006 ) .</brief_summary>
	<brief_title>Effects Lacosamide Human Motor Cortex Excitability : Transcranial Magnetic Stimulation Study</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>healthy male righthanded aged 1845 year cardiac pacemaker metal implant head intake medication previous neurologic , psychiatric , chronic internal disease pregnancy breastfeeding ; drug , nicotine , alcohol abuse know expect intolerance soy bean , peanut , LCM CBZ ; abnormal ECG prolong PQinterval participation another clinical trial within previous 8 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>lacosamide</keyword>
	<keyword>carbamazepine</keyword>
	<keyword>placebo</keyword>
	<keyword>transcranial magnetic stimulation</keyword>
	<keyword>TMS</keyword>
	<keyword>motor cortex</keyword>
	<keyword>sodium channel</keyword>
	<keyword>inhibition</keyword>
	<keyword>threshold</keyword>
</DOC>